Back to Press Release List

Indian Society of Hemodialysis to Feature Talk on Citrate Dialysate

March 8, 2004

Bellevue, WA, USA – 08 March – The inaugural congress of the Indian Society of Hemodialysis will include a talk by Dr. Suhail Ahmad on the topic of “Heparin Free Hemodialysis – The Role of Citrate Dialysate”. Dr. Ahmad is co-inventor of Citrasate® and DRYalysate®. The March 19-21, 2004 congress will take place at the Hotel Ashok in New Delhi, India, and is a collaborative event of the Indian Society of Hemodialysis and the International Society of Hemodialysis.

Citrasate® and DRYalysate® are patented acid concentrates using citric acid, a known anticoagulant. Citric acid-based dialysate concentrates are particularly helpful in better dialysis for those patients where heparin is contraindicated, such as heparin antibodies or allergies. The acid concentrate products are also helpful in acute dialysis where there is a risk of bleeding or clotting. Citrasate and DRYalysate have been shown to prevent dialyzer clotting, reduce metabolic acidosis and increase reuse of dialyzers. More information may be found at www.citrasate.com.